# Intensified liver-directed radionuclide therapy shows promise for patients with metastatic neuroendocrine tumors

Source: [Medical Xpress - latest medical and health news stories](https://medicalxpress.com/news/2026-11-liver-radionuclide-therapy-patients-metastatic.html) · 2026-11-13 · Medicine
Page: https://themorning.science/story/intensified-liver-directed-radionuclide-therapy-shows-promise-for-patients-with-f0e2cf19894ee37b
Kind: research · Impact: low

## In brief

- Combining intraarterial and intravenous administration of peptide receptor radionuclide therapy (PRRT) can selectively intensify treatment for liver-dominant metastatic neuroendocrine tumours.
- The approach still delivers treatment throughout the whole body, according to the source report.
- The report is a Medical Xpress news summary; the source text available is a short excerpt.

## Why it matters

It offers a way to concentrate radiation dose on liver-dominant metastatic neuroendocrine tumours while retaining systemic coverage, which may inform future treatment design for this patient group.

## Timeline

- 2026-11-13: Medical Xpress reported on intensified liver-directed PRRT for metastatic neuroendocrine tumours

## Coverage

- [Intensified liver-directed radionuclide therapy shows promise for patients with metastatic neuroendocrine tumors](https://medicalxpress.com/news/2026-11-liver-radionuclide-therapy-patients-metastatic.html) — Medical Xpress - latest medical and health news stories, 2026-11-13

Tags: neuroendocrine tumours, radionuclide therapy, PRRT, liver metastases, oncology

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science